A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
Status:
Completed
Trial end date:
2018-02-09
Target enrollment:
Participant gender:
Summary
The Automated Insulin Delivery (AID) System is an investigational insulin delivery device
being developed for use for participants with diabetes. The purpose of this study is to
assess the safety of the AID system and to test whether the AID System functions as it was
designed to.
This study will last approximately 12-18 days, not including screening. Screening is required
within 28 days prior to the start of the study.